StreetInsider.com News Articles

Form 8-K REGENEREX PHARMA, INC. For: Jun 11

Thu, 11 Jun 2026 13:52:00 -0400

si-local-file:///var/storage/secattach/20260611/26634931.html

Form 8-K REGENEREX PHARMA, INC. For: Jun 11

Thu, 11 Jun 2026 13:52:00 -0400

si-local-file:///var/storage/secattach/20260611/26634931.html

Form 8-K REGENEREX PHARMA, INC. For: May 06

Wed, 06 May 2026 11:55:00 -0400

si-local-file:///var/storage/secattach/20260506/26441877.html

Form 8-K REGENEREX PHARMA, INC. For: May 06

Wed, 06 May 2026 11:55:00 -0400

si-local-file:///var/storage/secattach/20260506/26441877.html

Form 8-K REGENEREX PHARMA, INC. For: Mar 31

Thu, 02 Apr 2026 17:13:00 -0400

si-local-file:///var/storage/secattach/20260402/26268434.html

Form 8-K REGENEREX PHARMA, INC. For: Mar 31

Thu, 02 Apr 2026 17:13:00 -0400

si-local-file:///var/storage/secattach/20260402/26268434.html

Form NT 10-K REGENEREX PHARMA, INC. For: Dec 31

Mon, 30 Mar 2026 17:57:00 -0400

si-local-file:///var/storage/secattach/20260330/26241926.html

Form NT 10-K REGENEREX PHARMA, INC. For: Dec 31

Mon, 30 Mar 2026 17:57:00 -0400

si-local-file:///var/storage/secattach/20260330/26241926.html

Form 10-Q REGENEREX PHARMA, INC. For: Sep 30

Mon, 17 Nov 2025 17:25:00 -0400

si-local-file:///var/storage/secattach/20251117/25626316.html

Form 10-Q REGENEREX PHARMA, INC. For: Sep 30

Mon, 17 Nov 2025 17:25:00 -0400

si-local-file:///var/storage/secattach/20251117/25626316.html

Form NT 10-Q REGENEREX PHARMA, INC. For: Sep 30

Mon, 17 Nov 2025 12:30:00 -0400

si-local-file:///var/storage/secattach/20251117/25624143.html

Form NT 10-Q REGENEREX PHARMA, INC. For: Sep 30

Mon, 17 Nov 2025 12:30:00 -0400

si-local-file:///var/storage/secattach/20251117/25624143.html

Form 8-K REGENEREX PHARMA, INC. For: Nov 11

Wed, 12 Nov 2025 15:10:00 -0400

si-local-file:///var/storage/secattach/20251112/25597228.html

Form 8-K REGENEREX PHARMA, INC. For: Nov 11

Wed, 12 Nov 2025 15:10:00 -0400

si-local-file:///var/storage/secattach/20251112/25597228.html

Regenerex Pharma, Inc. Enters Into Binding Supply and Development Agreement with Holista Colltech Ltd.

Wed, 03 Sep 2025 15:21:00 -0400

LAS VEGAS--(BUSINESS WIRE)-- Regenerex Pharma, Inc. (OTC: RGPX), a leading innovator in advanced wound closure systems for chronic wounds, today announced that it has entered into a binding supply and development agreement with Holista Colltech Ltd. of Perth, Australia.

Under terms of the agreement, Holista will exclusively manufacture and supply its proprietary ovine collagen, including its patented 300 kDa intact collagen and nano-collagen technologies, for Regenerex’s use in the development, clinical testing, and global distribution of advanced wound care products. The initial commercial focus will be the United States, with expansion into other global markets to follow.

Key Terms

Regenerex Pharma, Inc. Enters Into Binding Supply and Development Agreement with Holista Colltech Ltd.

Wed, 03 Sep 2025 15:21:00 -0400

LAS VEGAS--(BUSINESS WIRE)-- Regenerex Pharma, Inc. (OTC: RGPX), a leading innovator in advanced wound closure systems for chronic wounds, today announced that it has entered into a binding supply and development agreement with Holista Colltech Ltd. of Perth, Australia.
Under terms of the agreement, Holista will exclusively manufacture and supply its proprietary ovine collagen, including its patented 300 kDa intact collagen and nano-collagen technologies, for Regenerex’s use in the development, clinical testing, and global distribution of advanced wound care products. The initial commercial focus will be the United States, with expansion into other global markets to follow.
Key Terms

Form 8-K REGENEREX PHARMA, INC. For: Sep 03

Wed, 03 Sep 2025 14:56:00 -0400
si-local-file:///var/storage/secattach/20250903/25291407.html

Regenerex Pharma enters licensing deal with Holista Colltech

Thu, 31 Jul 2025 17:43:31 -0400

Regenerex Pharma, Inc. (OTC: RGPX) announced a licensing agreement with Holista Colltech Ltd. to integrate ovine nano-collagen into its wound healing products. The partnership will combine Holista's ovine collagen with Regenerex's QBx technology for wound care applications.
Under the agreement, Regenerex will incorporate ovine nano-collagen sourced from Australian sheep into its wound healing protocols. The company stated the material will be used to create scaffolding matrices for cellular growth in deep tissue regeneration cases.
"Ovine collagen represents a significant step forward in wound care innovation," said Greg Pilant, CEO of Regenerex Pharma. "Unlike traditional mammalian sources such as bovine or porcine collagen,

Regenerex Pharma, Inc. Enters Into Licensing Agreement with Holista Colltech Ltd.

Thu, 31 Jul 2025 17:43:00 -0400

New Wound Healing Breakthrough With Ovine Nano-Collagen QBx™ Integration

LAS VEGAS--(BUSINESS WIRE)-- Regenerex Pharma, Inc. (OTC: RGPX), a leading innovator in advanced wound closure systems for chronic wounds, today announced the development of new product formulations designed to accelerate deep tissue regeneration through enhanced scaffolding facilitation and cell proliferation. Building on its patented QBx™ technology, Regenerex will now incorporate ovine nano-collagen into its wound healing protocols. This highly refined biomaterial, due to its ultra-small molecular size, provides an ideal scaffolding matrix to support and accelerate cellular growth, making it especially beneficial in cases requiring deeper tissue regeneration.
As

Regenerex Pharma, Inc. Enters Into Licensing Agreement with Holista Colltech Ltd.

Thu, 31 Jul 2025 17:43:00 -0400

New Wound Healing Breakthrough With Ovine Nano-Collagen QBx™ Integration

LAS VEGAS--(BUSINESS WIRE)-- Regenerex Pharma, Inc. (OTC: RGPX), a leading innovator in advanced wound closure systems for chronic wounds, today announced the development of new product formulations designed to accelerate deep tissue regeneration through enhanced scaffolding facilitation and cell proliferation. Building on its patented QBx™ technology, Regenerex will now incorporate ovine nano-collagen into its wound healing protocols. This highly refined biomaterial, due to its ultra-small molecular size, provides an ideal scaffolding matrix to support and accelerate cellular growth, making it especially beneficial in cases requiring deeper tissue regeneration.
As

Form 8-K REGENEREX PHARMA, INC. For: Jul 31

Thu, 31 Jul 2025 15:44:00 -0400
si-local-file:///var/storage/secattach/20250731/25129740.html

Form 10-K REGENEREX PHARMA, INC. For: Mar 31

Mon, 30 Jun 2025 15:52:00 -0400
si-local-file:///var/storage/secattach/20250630/24997792.html

Form 8-K REGENEREX PHARMA, INC. For: Mar 31

Wed, 02 Apr 2025 15:16:00 -0400
si-local-file:///var/storage/secattach/20250402/24589975.html

Form 10-Q REGENEREX PHARMA, INC. For: Dec 31

Fri, 07 Feb 2025 12:22:00 -0400
si-local-file:///var/storage/secattach/20250207/24314434.html

Form 8-K REGENEREX PHARMA, INC. For: Dec 10

Tue, 10 Dec 2024 17:13:00 -0400
si-local-file:///var/storage/secattach/20241210/24089192.html